Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Kidney International|December 28, 2020
Empagliflozin restores chronic kidney disease-induced impairment of endothelial regulation of cardiomyocyte relaxation and contractionRio P Juni, Rushd Al-Shama, Diederik W D Kuster, et al.
Clinical Nutrition (Edinburgh, Scotland)|December 26, 2008
Butyrate modulates oxidative stress in the colonic mucosa of healthy humansHenrike M Hamer, Daisy M A E Jonkers, Aalt Bast, et al.
The Journal of Clinical Endocrinology and Metabolism|November 14, 2018
The Muscle Protein Synthetic Response to Whey Protein Ingestion Is Greater in Middle-Aged Women Compared With MenAstrid M H Horstman, Imre W K Kouw, Jan-Willem van Dijk, et al.
Plos One|November 12, 2015
Post-Prandial Protein Handling: You Are What You Just AteBart B L Groen, Astrid M Horstman, Henrike M Hamer, et al.
The Journal of Clinical Endocrinology and Metabolism|August 27, 2015
Impact of the Macronutrient Composition of a Nutritional Supplement on Muscle Protein Synthesis Rates in Older Men: A Randomized, Double Blind, Controlled TrialIrene Fleur Kramer, Lex B Verdijk, Henrike M Hamer, et al.
The Journal of Clinical Endocrinology and Metabolism|October 18, 2016
Increasing Insulin Availability Does Not Augment Postprandial Muscle Protein Synthesis Rates in Healthy Young and Older MenBart B L Groen, Astrid M H Horstman, Henrike M Hamer, et al.
The Journal of Physiology|August 12, 2016
Systemic availability and metabolism of colonic-derived short-chain fatty acids in healthy subjects: a stable isotope studyEef Boets, Sara V Gomand, Lise Deroover, et al.
Clinical Nutrition (Edinburgh, Scotland)|October 17, 2016
Both basal and post-prandial muscle protein synthesis rates, following the ingestion of a leucine-enriched whey protein supplement, are not impaired in sarcopenic older malesIrene Fleur Kramer, Lex B Verdijk, Henrike M Hamer, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 24, 2025
Prognostic Value of the TLM3 Biomarker Panel for Early Fibrosis Development in MASLD Within the General PopulationKoen C van Son, Jelle C B C de Jong, Serdar Özsezen, et al.
Clinical Chemistry and Laboratory Medicine|June 19, 2026
Reagent-specific anti-Xa DOAC safety cutoffs can be established using multiple LMWH-calibrated anti-Xa assaysThomas Nieuwenstein, Ivan P Stoffer, Dave L S Hellenbrand, et al.
Pageof 5